Long-term phase of schizophrenia: Impact of atypical agents

International Clinical Psychopharmacology

Volumn 15, Issue SUPPL. 4, 2000, Pages

  Naber, D ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Amisulpride; Clozapine; Cognitive deficits; Compliance; Flupentixol; Haloperidol; Long term; Negative symptoms; Quality of life; Side effects

Indexed keywords

AMISULPRIDE; CLOZAPINE; FLUPENTIXOL; HALOPERIDOL; NEUROLEPTIC AGENT;

COGNITIVE DEFECT; CONFERENCE PAPER; HUMAN; LONG TERM CARE; NEGATIVE SYNDROME; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; QUALITY OF LIFE; SCHIZOPHRENIA; WELLBEING;

ANTIPSYCHOTIC AGENTS; COGNITION DISORDERS; HUMANS; PATIENT COMPLIANCE; QUALITY OF LIFE; RECURRENCE; SCHIZOPHRENIA;

EID: 0034471681     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Treatment adherence
2. Quality of life in schizophrenia: Long-term follow-up in 362 chronic Spanish schizophrenic out-patients undergoing risperidone maintenance treatment
3. A two-year prospective study of treatment compliance in patients with schizophrenia
4. Quality of life: Superiority of amisulpride versus haloperidol: A 12-month study
5. Clozapine eligibility among State hospital patients
6. Clozapine: Progress in treating refractory schizophrenia
7. Tardive dyskinesia: Epidemiological and clinical presentation
8. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine
9. Efficacy and safety of amisulpride versus halperidol: A 4-month assessment
10. Clinical effects of clozapine in chronic schizophrenia: Response to treatment and predictors of outcome
11. Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia
12. Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients
13. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients
14. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables
15. Clinical management of clozapine patients in relation to efficacy and side-effects
16. Clozapine treatment in Denmark: Concomitant psychotropic medication and hematologic monitoring in a system with liberal usage practices
17. Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: Quality of life and clinical outcomes of a randomized clinical trial
18. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia
19. Akathisia and clozapine treatment